triple negative breast cancer | Клиническая онкология

Erlotinib (Tarceva) as first-line treatment for patients with non-small cell lung cancer with EGFR mutations: analysis of effectiveness
№1(13) 2014

Vaginal cancer: current state of the problem
Authors: Vorobyova L.I. Nespryadko S.V. Goncharuk I.V. Gavrylyuk O.М.... №1(13) 2014

Effectiveness of support therapy algorithms based on chemotherapy toxicity prognostic factors in patients with breast cancer
Authors: Sivak L.A. Gubareva G.O. Lyalkin S. Mаydаnеvich N.... №1(13) 2014

Chronic lymphocytic leukemia: new in treatment Approaches to the first-line treatment and their evolution
Author:Kryachok I. №3(11) 2013

Triple negative breast cancer: current view on the problem
Authors: Sivak L.A. Lyalkin S. Mаydаnеvich N. Klimаnоv М.Yu.... №3(11) 2013

Chemotherapy in patients with malignant tumors of the ovary
Author:Svintsitsky V.S. №3(11) 2013

Prognostic risk factors of unfavorable Hodgkin’s lymphoma’s run: standard and new
Authors: Novosad I.O. Kryachok I. Khranovskaya N.M. Svеrgun N.N.... №3(11) 2013

A clinical study of the efficacy of paclitaxel and bevacizumab as first-line therapy for HER2-negative breast cancer
№1(9) 2013

Hepatotoxicity in patients with cancer pathology (diagnosis, treatment)
Authors: Karnabeda O.A. Tkach S.M Perederiy V.G Chichulay J.V №1(9) 2013

Treatment and prevention of toxic phlebitis induced by chemotherapy in patients with breast cancer
Authors: Sivak L.A. Gubаrеvа А.А. Lyalkin S. Mаydаnеvich N.... №1(9) 2013

Therapeutic strategy in unresectable metastatic colorectal cancer
Authors: B. Chibaudel Tournigand C. André T. A. de Gramont №7 (3) 2012

Chemotherapy in the treatment of patients with cervical cancer stage IIB
Author:Kryzhanivska A.E. №7 (3) 2012

Assessment of hematologic toxicity of standard FAC chemotherapy in patients with malignant breast tumors
Authors: Kryachok I. Sivak L.A. Aleksyk O.M. Gubаrеvа А.А.... №7 (3) 2012

The use of modifiers — a way to improve efficiency of treatment of primary inoperable breast cancer patients
Authors: Smolanka I. Ivankova V.S. Skliar S. Ivankova O.N. №6 (2) 2012

Necessity and choice of preoperative therapy for patients with esophageal cancer
Authors: Ganul V.L. Kirkilevskyi S.I. Krakhmalov S.N. Kondratskyi Y.... №6 (2) 2012


Log in Registration Search for: Home Online Publication Current Issue Issue Archive Authors About Information About the Journal Focus and Scope Indexing For Authors Submission Guidelines and Requirements Peer Review Article Processing Charges Copyright and Licensing Policies Editorial Policy Plagiarism Policy Archiving Policy Policy on the Use of Artificial Intelligence (AI) and AI-Supported Technologies Open Access Procedure for the Retraction of Published Articles Ethical Issues Publication Ethics Procedure for Handling Complaints Regarding Ethical Breaches Privacy Statement International Standards and Principles of Operation
Organization of anticancer fight Tumors of the chest cavity Tumors of abdominal organs Tumors of skin, soft tissues, bones Breast tumor Oncogynecology Tumors of the head and neck Oncurology Oncohematology Radiation diagnostics, radiation therapy Experimental studies Magazine online All news	Keyword : triple negative breast cancer Erlotinib (Tarceva) as first-line treatment for patients with non-small cell lung cancer with EGFR mutations: analysis of effectiveness №1(13) 2014 Vaginal cancer: current state of the problem Authors: Vorobyova L.I. Nespryadko S.V. Goncharuk I.V. Gavrylyuk O.М.... №1(13) 2014 Effectiveness of support therapy algorithms based on chemotherapy toxicity prognostic factors in patients with breast cancer Authors: Sivak L.A. Gubareva G.O. Lyalkin S. Mаydаnеvich N.... №1(13) 2014 Chronic lymphocytic leukemia: new in treatment Approaches to the first-line treatment and their evolution Author:Kryachok I. №3(11) 2013 Triple negative breast cancer: current view on the problem Authors: Sivak L.A. Lyalkin S. Mаydаnеvich N. Klimаnоv М.Yu.... №3(11) 2013 Chemotherapy in patients with malignant tumors of the ovary Author:Svintsitsky V.S. №3(11) 2013 Prognostic risk factors of unfavorable Hodgkin’s lymphoma’s run: standard and new Authors: Novosad I.O. Kryachok I. Khranovskaya N.M. Svеrgun N.N.... №3(11) 2013 A clinical study of the efficacy of paclitaxel and bevacizumab as first-line therapy for HER2-negative breast cancer №1(9) 2013 Hepatotoxicity in patients with cancer pathology (diagnosis, treatment) Authors: Karnabeda O.A. Tkach S.M Perederiy V.G Chichulay J.V №1(9) 2013 Treatment and prevention of toxic phlebitis induced by chemotherapy in patients with breast cancer Authors: Sivak L.A. Gubаrеvа А.А. Lyalkin S. Mаydаnеvich N.... №1(9) 2013 Therapeutic strategy in unresectable metastatic colorectal cancer Authors: B. Chibaudel Tournigand C. André T. A. de Gramont №7 (3) 2012 Chemotherapy in the treatment of patients with cervical cancer stage IIB Author:Kryzhanivska A.E. №7 (3) 2012 Assessment of hematologic toxicity of standard FAC chemotherapy in patients with malignant breast tumors Authors: Kryachok I. Sivak L.A. Aleksyk O.M. Gubаrеvа А.А.... №7 (3) 2012 The use of modifiers — a way to improve efficiency of treatment of primary inoperable breast cancer patients Authors: Smolanka I. Ivankova V.S. Skliar S. Ivankova O.N. №6 (2) 2012 Necessity and choice of preoperative therapy for patients with esophageal cancer Authors: Ganul V.L. Kirkilevskyi S.I. Krakhmalov S.N. Kondratskyi Y.... №6 (2) 2012 «1 234 5 »
MORION Publishing House Editorial office and publisher: 02140, Kyiv, ave. Bazhana 10A Tel.: 380 (44) 585-97-10 Specialized medical online publication for doctors, pharmacists, pharmacists, medical students and pharmaceutical universities.Disclaimer morion.ua apteka.ua pharmstandart.com.ua compendium.com.ua proximaresearch.com

Magazine online

Keyword : triple negative breast cancer